Hong Kong stocks new shares of Danao Medicine surged nearly 100% during the public offering stage, with oversubscription exceeding 9000 times.

Livemore Securities shows that, as of press time, Dano Medicine-B has increased by 98.15%. In terms of news, the company received 9015.11 times oversubscription in the public offering stage and 9.24 times oversubscription in the international placement stage.